Skip to main content

Medication & Treatment

People with diabetes use many medications to both manage blood sugar levels and also to prevent or treat health complications.

For people with type 1 diabetes, the most important drug is insulin; some people with type 2 diabetes also take insulin. For people with type 2 diabetes, glucose-lowering medications include metformin, sulfonylureas, TZDs, SGLT-2 inhibitors, GLP-1 agonists, DPP-4 inhibitors, and more.

Some of these drugs are injected, others are taken in pill form, and some are even inhaled. Learn about the different treatment options available and which might be best for your lifestyle.

Metformin
Insulin
SGLT-2 inhibitors
GLP-1 agonists
DPP-4 inhibitors
Combination drugs
Sulfonylureas (SFUs)
TZDs

What's new

GLP-1 agonists are a class of drug recommended for people with type 2 diabetes to lower glucose and body weight, and for heart and stroke protection in those with heart disease. Learn more about these medicines, including their side effects, how they work, and their role in diabetes and heart health Continue Reading »

More people with diabetes are taking drugs like Jardiance and Farxiga, originally developed to lower glucose in people with type 2 diabetes, because the latest data confirms that these drugs can protect your kidneys. A therapy still under investigation, finerenone, has been developed to protect the kidneys of people with and without diabetes Continue Reading »

SGLT-2 inhibitors can protect your heart! This type of medicine is recommended for people with type 2 diabetes who have heart disease or risk factors related to heart disease. Learn about the use of these medicines, including side effects, their effect on A1C, and their role in supporting heart health Continue Reading »

New SGLT-2 inhibitor and GLP-1 agonist diabetes medication recommendations for people with type 2 diabetes Continue Reading »

Semglee may provide a cheaper alternative to Lantus (insulin glargine) – it costs $148 for five pre-filled insulin pens. Continue Reading »

Latest results presented at the European Society of Cardiology conference show that SGLT-2 inhibitor therapies Jardiance and Farxiga clearly lead to heart and kidney health Continue Reading »

The FDA approved higher doses of the GLP-1 agonist, Trulicity, after powerful clinical trial results showed that the increased medication can help people lower their A1C and lose weight Continue Reading »

Diabetes and heart disease are closely connected. This article discusses heart disease, important numbers to know, and ways to improve your heart health  Continue Reading »

Pages